Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
regeneron pharmaceuticals
rna interference
2
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
a2 biotherapeutics
aduro biotech
agency
akcea therapeutics
akili interactive labs
alicia hager
alnylam pharmaceuticals
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amgen
arca biopharma
arch venture partners
arrowhead pharmaceuticals
axovant gene therapies
bacteriophage
barry greene
biogen
biontech
biotech ipos
boston
boston university
boulder/denver blog main
boulder/denver top stories
What
time
2
×
ago
alliance
alnylam
approve
awaits
bio
biological
bristol
buy
calls
changing
color
crispr
crossed
days
decades
decision
discovered
fda
fingers
friday
growing
historic
hours
kudos
leaves
medicine
myers’s
notifying
october
patients
phone
rna
rnai
roundup
rouse
scientists
shorter
slumber
Language
unset
Current search:
time
×
biotech
×
" rna interference "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision